Anthrasil Liquid
Product Images NDC 60492-0249

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Anthrasil (NDC 60492-0249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Biosolutions Canada Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Anthrasil Vial Label (Shelf Carton Label Ndc 60492 0249 2)

Anthrasil Vial Label (Shelf Carton Label Ndc 60492 0249 2)
This is a product description for NDC60492-0249-1 Anthrax Immune Globulin. The product is for intravenous use only and should not be shaken to avoid foaming. It contains no preservatives and is to be stored at temperatures below -15°C. The product is intended for strategic national stockpile use, with distribution being handled by the Centers for Disease Control and Prevention. The lot number, manufacturing date, and dosage information are provided on the label.*
FDA Label Image

Mean Tna Activities For Three Doses Of Anthrasil (Image 01)

Mean Tna Activities For Three Doses Of Anthrasil (Image 01)
This appears to be a graph displaying data on a semi-log scale. The x-axis shows the time in days after a dose, while the y-axis is not visible in the provided text. The numbers listed on the x-axis range from 0 to 84, and there are markings indicating the values 4, 8, 12, etc. The rest of the characters are likely part of labels or data points on the graph.*
FDA Label Image

Anthrasil Carton Label (Image 02)

Anthrasil Carton Label (Image 02)
This is a description of Anthrax Immune Globulin that contains 260 units per vial and is for use only by the Strategic National Stockpile. It is recommended to store the product at temperatures below <-15°C (<5°F) and should be used within 48 hours of thawing. The product does not contain any preservatives, and it is for intraveneous use only. The package insert should be referred to for directions, and patients should avoid shaking the vials and foaming. Emergent BioSolutions Canada Inc. produced Anthrasil, and it is distributed by the Centers for Disease Control and Prevention, Atlanta, GA. The lot number and expiry date are also available. The text is a pharmaceutical product warning and usage instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.